Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ALEMBIC PHARMA ABBOTT INDIA/
ALEMBIC PHARMA
 
P/E (TTM) x 50.0 32.2 155.1% View Chart
P/BV x 18.2 4.4 411.9% View Chart
Dividend Yield % 1.2 0.8 148.1%  

Financials

 ABBOTT INDIA   ALEMBIC PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
ALEMBIC PHARMA
Mar-23
ABBOTT INDIA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs22,482792 2,837.5%   
Low Rs16,156463 3,487.2%   
Sales per share (Unadj.) Rs2,517.0287.6 875.3%  
Earnings per share (Unadj.) Rs446.817.4 2,567.9%  
Cash flow per share (Unadj.) Rs479.731.4 1,527.2%  
Dividends per share (Unadj.) Rs325.008.00 4,062.5%  
Avg Dividend yield %1.71.3 132.0%  
Book value per share (Unadj.) Rs1,480.5222.3 665.8%  
Shares outstanding (eoy) m21.25196.56 10.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.72.2 351.6%   
Avg P/E ratio x43.236.1 119.8%  
P/CF ratio (eoy) x40.320.0 201.5%  
Price / Book Value ratio x13.02.8 462.1%  
Dividend payout %72.746.0 158.2%   
Avg Mkt Cap Rs m410,513123,402 332.7%   
No. of employees `000NANA-   
Total wages/salary Rs m5,63611,691 48.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,48756,526 94.6%  
Other income Rs m1,54330 5,075.3%   
Total revenues Rs m55,03056,557 97.3%   
Gross profit Rs m12,0556,772 178.0%  
Depreciation Rs m7002,754 25.4%   
Interest Rs m160502 31.9%   
Profit before tax Rs m12,7383,546 359.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,244126 2,572.6%   
Profit after tax Rs m9,4943,420 277.6%  
Gross profit margin %22.512.0 188.1%  
Effective tax rate %25.53.6 716.2%   
Net profit margin %17.86.1 293.4%  
BALANCE SHEET DATA
Current assets Rs m30,25129,139 103.8%   
Current liabilities Rs m12,06016,408 73.5%   
Net working cap to sales %34.022.5 151.0%  
Current ratio x2.51.8 141.2%  
Inventory Days Days8710 896.4%  
Debtors Days Days27 32.0%  
Net fixed assets Rs m15,13531,498 48.0%   
Share capital Rs m213393 54.1%   
"Free" reserves Rs m31,24843,312 72.1%   
Net worth Rs m31,46043,705 72.0%   
Long term debt Rs m00-   
Total assets Rs m45,38660,637 74.8%  
Interest coverage x80.78.1 999.8%   
Debt to equity ratio x00-  
Sales to assets ratio x1.20.9 126.4%   
Return on assets %21.36.5 328.9%  
Return on equity %30.27.8 385.7%  
Return on capital %41.09.3 442.7%  
Exports to sales %0.446.4 0.9%   
Imports to sales %10.812.1 89.0%   
Exports (fob) Rs m22126,210 0.8%   
Imports (cif) Rs m5,7656,846 84.2%   
Fx inflow Rs m31026,210 1.2%   
Fx outflow Rs m5,8186,846 85.0%   
Net fx Rs m-5,50819,364 -28.4%   
CASH FLOW
From Operations Rs m8,9347,240 123.4%  
From Investments Rs m-1,477-4,476 33.0%  
From Financial Activity Rs m-6,387-2,620 243.8%  
Net Cashflow Rs m1,070144 743.3%  

Share Holding

Indian Promoters % 0.0 69.1 -  
Foreign collaborators % 75.0 0.5 14,703.9%  
Indian inst/Mut Fund % 8.9 19.0 46.9%  
FIIs % 0.2 4.5 4.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 30.4 82.3%  
Shareholders   72,252 85,212 84.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs ALEMBIC PHARMA Share Price Performance

Period Abbott India ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day 0.74% -0.15% 1.18%
1-Month -5.97% -4.30% -0.75%
1-Year 24.80% 105.43% 61.82%
3-Year CAGR 21.40% 0.89% 18.16%
5-Year CAGR 29.91% 13.56% 19.79%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of Abbott India, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.